RGS17 and hepatocellular carcinoma: Regarding miR-199, previous data showed that this miRNA was associated with cell cycle processes in HCC via XBP1/cyclin D and acted as a tumor suppressor by targeting RGS17 in the inhibition of tumor growth [27].